Mint Tower Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Mint Tower Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-58,000	Closed	-$4.24M	–	425
2022 Q1	$4.24M	Buy	+58,000	New	+$3.89M	0.39%	39
2021 Q4	–	Sell	-39,400	Closed	-$2.33M	–	362
2021 Q3	$2.33M	Sell	39,400 -11,000	-22%	-$724K	0.3%	64
2021 Q2	$3.37M	Buy	50,400 +18,200	+57%	+$1.19M	0.24%	68
2021 Q1	$2.03M	Buy	32,200 +7,700	+31%	+$479K	0.19%	73
2020 Q4	$15K	Buy	+24,500	New	+$1.51M	﹤0.01%	107
2019 Q4	–	Sell	-12,000	Closed	-$609K	–	226
2019 Q3	$609K	Buy	+12,000	New	+$564K	0.09%	133
2018 Q3	–	Sell	-12,500	Closed	-$692K	–	203
2018 Q2	$692K	Buy	+12,500	New	+$675K	0.09%	135

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mint Tower Capital Management's BMY Position: Q4 2021 in Review

Mint Tower Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 1,260 shares — an estimated $75K sold.

Mint Tower Capital Management first reported a position in BMY in Q3 2021 and held it in 1 quarter. The position peaked at $75K in Q3 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Mint Tower Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Mint Tower Capital Management sold 1,260 Bristol-Myers Squibb shares in Q4 2021, an estimated $75K.
Mint Tower Capital Management first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 1 quarter.
Mint Tower Capital Management's Bristol-Myers Squibb position peaked at $75K in Q3 2021.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Mint Tower Capital Management's 13F filing for Q4 2021, filed 4 Feb 2022.